Researchers Identify Common Cancer Weakness, Paving Way for Targeted Drugs

The briefing

Medical Xpress reports that a Weill Cornell Medicine–led team found a common vulnerability across multiple cancers and has begun designing compounds to exploit it. The approach could enable potent treatments with fewer side effects for colorectal, breast, and other cancers, pending further study.